Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

被引：0
|
作者：
Sam Razavi
Laurent Kodjikian
Audrey Giocanti-Aurégan
Ingrid Dufour
Eric Souied
机构：
[1] Centre d’Ophtalmologie,
[2] Centre Hospitalier de la Cr Rousse,undefined
[3] Université de Lyon,undefined
[4] Hôpital Avicenne,undefined
[5] AP-HP,undefined
[6] Université Paris 13,undefined
[7] DHU Vision et Handicaps,undefined
[8] Bayer HealthCare SAS,undefined
[9] Centre Hospitalier Intercommunal de Créteil,undefined
来源：
BMC Ophthalmology | / 21卷
关键词：
Retina; Age-related macular degeneration; Exudative; Switch; Observational;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The efficacy of aflibercept in the treatment of neovascular age-related macular degeneration previously treated with bevacizumab or ranibizumab
    Hall, Laura
    Zebardast, Nazlee
    Adelman, Ron
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [32] Evaluation of the Effects of Intravitreal Aflibercept and Ranibizumab on Systemic Inflammatory and Cardiovascular Biomarkers in Patients with Neovascular Age-related Macular Degeneration
    Erdem, Burak
    Gok, Mustafa
    CURRENT EYE RESEARCH, 2021, 46 (09) : 1387 - 1392
  • [33] Characteristics of patients with neovascular age-related macular degeneration who are nonresponders to intravitreal aflibercept
    Hara, Chikako
    Wakabayashi, Taku
    Toyama, Hiroshi
    Fukushima, Yoko
    Sayanagi, Kaori
    Sato, Shigeru
    Sakaguchi, Hirokazu
    Nishida, Kohji
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (05) : 623 - 629
  • [34] INTRAVITREAL AFLIBERCEPT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION RESISTANT TO INTRAVITREAL RANIBIZUMAB
    Narayan, Daniel
    Muecke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 119 - 119
  • [35] Intravitreal aflibercept versus intravitreal ranibizumab in patients with age-related macular degeneration: a comparative effectiveness study
    Smit, Cornelis
    Wiertz-Arts, Karin
    van de Garde, Ewoudt M. W.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (06) : 561 - 567
  • [36] Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
    Mantel, Irmela
    Gillies, Mark C.
    Souied, Eric H.
    SURVEY OF OPHTHALMOLOGY, 2018, 63 (05) : 638 - 645
  • [37] Efficacy and Safety of Aflibercept in Fibrovascular Retinal Pigment Epithelium Detachment refractory to prior ranibizumab therapy in neovascular Age-related macular degeneration (AMD).
    Thi Ha Chau Tran
    Dumas, Stephane
    Coscas, Florence
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [38] Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
    Said, Yasmin Ali
    Vanwynsberghe, David
    Jacob, Julie
    CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (01): : 247 - 252
  • [39] Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration
    Florian M. Heussen
    Qing Shao
    Yanling Ouyang
    Antonia M. Joussen
    Bert Müller
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 909 - 915
  • [40] Aflibercept for neovascular age-related macular degeneration
    Sarwar, Salman
    Clearfield, Elizabeth
    Soliman, Mohamed Kamel
    Sadiq, Mohammad Ali
    Baldwin, Andrew J.
    Hanout, Mostafa
    Agarwal, Aniruddha
    Sepah, Yasir J.
    Do, Diana V.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
12345